Latest Insider Transactions at Albireo Pharma, Inc. (ALBO)
This section provides a real-time view of insider transactions for Albireo Pharma, Inc. (ALBO). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ALBIREO PHARMA, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ALBIREO PHARMA, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 22
2022
|
Jason Duncan Chief Legal Officer and GC |
SELL
Open market or private sale
|
Direct |
344
-1.06%
|
$8,256
$24.57 P/Share
|
|
Jul 22
2022
|
Ronald Harold Wilfred Cooper President and CEO |
SELL
Open market or private sale
|
Direct |
929
-1.62%
|
$22,296
$24.67 P/Share
|
|
Jul 12
2022
|
Simon N.R. Harford CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
95
-0.28%
|
$2,280
$24.03 P/Share
|
|
Jun 27
2022
|
Pamela Stephenson Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
461
-1.0%
|
$8,759
$19.47 P/Share
|
|
Apr 25
2022
|
Jason Duncan Chief Legal Officer and GC |
SELL
Open market or private sale
|
Direct |
312
-0.96%
|
$10,296
$33.42 P/Share
|
|
Apr 22
2022
|
Jason Duncan Chief Legal Officer and GC |
SELL
Open market or private sale
|
Direct |
343
-1.03%
|
$11,319
$33.0 P/Share
|
|
Apr 22
2022
|
Ronald Harold Wilfred Cooper President and CEO |
SELL
Open market or private sale
|
Direct |
907
-1.59%
|
$29,931
$33.11 P/Share
|
|
Apr 22
2022
|
Pamela Stephenson Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
103
-0.22%
|
$3,296
$32.92 P/Share
|
|
Apr 22
2022
|
Simon N.R. Harford CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
103
-0.3%
|
$3,296
$32.92 P/Share
|
|
Apr 22
2022
|
Michelle Graham Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
103
-0.39%
|
$3,296
$32.92 P/Share
|
|
Apr 22
2022
|
Jan Mattsson Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
200
-0.34%
|
$6,400
$32.92 P/Share
|
|
Apr 22
2022
|
Martha J. Carter Chief Regulatory Officer |
SELL
Open market or private sale
|
Direct |
103
-0.65%
|
$3,296
$32.92 P/Share
|
|
Apr 11
2022
|
Simon N.R. Harford CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
96
-0.28%
|
$3,360
$35.74 P/Share
|
|
Mar 28
2022
|
Pamela Stephenson Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
454
-0.97%
|
$13,620
$30.52 P/Share
|
|
Jan 24
2022
|
Michelle Graham Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
418
-1.54%
|
$10,032
$24.72 P/Share
|
|
Jan 24
2022
|
Martha J. Carter Chief Regulatory Officer |
SELL
Open market or private sale
|
Direct |
423
-2.6%
|
$10,152
$24.52 P/Share
|
|
Jan 24
2022
|
Ronald Harold Wilfred Cooper President and CEO |
SELL
Open market or private sale
|
Direct |
3,684
-6.07%
|
$88,416
$24.88 P/Share
|
|
Jan 24
2022
|
Jan Mattsson Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
808
-1.37%
|
$19,392
$24.88 P/Share
|
|
Jan 24
2022
|
Pamela Stephenson Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
416
-0.88%
|
$9,984
$24.88 P/Share
|
|
Jan 24
2022
|
Simon N.R. Harford CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
416
-1.21%
|
$9,984
$24.88 P/Share
|
|
Jan 24
2022
|
Jason Duncan Chief Legal Officer and GC |
SELL
Open market or private sale
|
Direct |
1,688
-3.13%
|
$40,512
$24.97 P/Share
|
|
Jan 18
2022
|
Pamela Stephenson Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,600
+31.4%
|
-
|
|
Jan 18
2022
|
Jason Duncan Chief Legal Officer and GC |
BUY
Grant, award, or other acquisition
|
Direct |
10,800
+37.05%
|
-
|
|
Jan 18
2022
|
Simon N.R. Harford CFO and Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
21,600
+38.64%
|
-
|
|
Jan 18
2022
|
Michelle Graham Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,600
+44.35%
|
-
|
|
Jan 18
2022
|
Martha J. Carter Chief Regulatory Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,800
+39.85%
|
-
|
|
Jan 18
2022
|
Jan Mattsson Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,600
+26.74%
|
-
|
|
Jan 11
2022
|
Simon N.R. Harford CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
111
-0.87%
|
$2,775
$25.95 P/Share
|
|
Dec 27
2021
|
Pamela Stephenson Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
474
-1.82%
|
$10,902
$23.92 P/Share
|
|
Oct 25
2021
|
Jason Duncan Chief Legal Officer and GC |
SELL
Open market or private sale
|
Direct |
217
-2.87%
|
$6,293
$29.21 P/Share
|
|
Oct 22
2021
|
Jason Duncan Chief Legal Officer and GC |
SELL
Open market or private sale
|
Direct |
95
-1.24%
|
$2,660
$28.85 P/Share
|
|
Oct 22
2021
|
Patrick Taylor Horn Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
95
-0.76%
|
$2,660
$28.83 P/Share
|
|
Oct 11
2021
|
Simon N.R. Harford CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
93
-0.73%
|
$2,790
$30.23 P/Share
|
|
Sep 27
2021
|
Pamela Stephenson Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
451
-1.7%
|
$14,432
$32.05 P/Share
|
|
Sep 17
2021
|
Ronald Harold Wilfred Cooper President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,760
-11.34%
|
$225,040
$29.61 P/Share
|
|
Sep 17
2021
|
Ronald Harold Wilfred Cooper President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
11,973
+14.89%
|
$227,487
$19.19 P/Share
|
|
Jul 23
2021
|
Jason Duncan Chief Legal Officer and GC |
SELL
Open market or private sale
|
Direct |
223
-2.83%
|
$6,913
$31.43 P/Share
|
|
Jul 22
2021
|
Jason Duncan Chief Legal Officer and GC |
SELL
Open market or private sale
|
Direct |
90
-1.13%
|
$3,060
$34.13 P/Share
|
|
Jul 22
2021
|
Patrick Taylor Horn Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
90
-0.72%
|
$3,060
$34.13 P/Share
|
|
Jul 13
2021
|
Simon N.R. Harford CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
98
-0.77%
|
$3,430
$35.02 P/Share
|
|
Jun 25
2021
|
Pamela Stephenson Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
471
-1.75%
|
$16,956
$36.01 P/Share
|
|
Jun 25
2021
|
Jason Duncan Chief Legal Officer and GC |
SELL
Open market or private sale
|
Direct |
6,300
-44.12%
|
$226,800
$36.22 P/Share
|
|
Jun 25
2021
|
Jason Duncan Chief Legal Officer and GC |
BUY
Exercise of conversion of derivative security
|
Direct |
6,300
+30.61%
|
$151,200
$24.67 P/Share
|
|
Jun 24
2021
|
Jason Duncan Chief Legal Officer and GC |
SELL
Open market or private sale
|
Direct |
10,000
-55.62%
|
$360,000
$36.38 P/Share
|
|
Jun 24
2021
|
Jason Duncan Chief Legal Officer and GC |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+19.69%
|
$240,000
$24.36 P/Share
|
|
Apr 23
2021
|
Jason Duncan Chief Legal Officer and GC |
SELL
Open market or private sale
|
Direct |
222
-2.75%
|
$7,104
$32.32 P/Share
|
|
Apr 22
2021
|
Patrick Taylor Horn Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
90
-0.75%
|
$2,790
$31.75 P/Share
|
|
Apr 22
2021
|
Jason Duncan Chief Legal Officer and GC |
SELL
Open market or private sale
|
Direct |
90
-1.1%
|
$2,790
$31.75 P/Share
|
|
Apr 12
2021
|
Simon N.R. Harford CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
92
-0.75%
|
$2,944
$32.12 P/Share
|
|
Apr 01
2021
|
Jason Duncan Chief Legal Officer and GC |
SELL
Open market or private sale
|
Direct |
300
-3.55%
|
$10,800
$36.16 P/Share
|